Community Health Systems, a Franklin, Tennessee-based for-profit hospital operator, had been under financial strain, posting a net loss for 2024 and facing rising medical specialist fees and payer claim denials. In 2024 CHS set a goal of divesting $1 billion in assets to deleverage its balance sheet, and by the first quarter of 2025 it was still working through that program while a $13 million net loss for the quarter showed the underlying pressure had not gone away.

In Q1 2025, CHS completed three divestitures -- ShorePoint Health System in Florida, Lake Norman Regional Medical Center in North Carolina, and its 50% stake in Merit Health Biloxi in Mississippi -- generating $544 million in cash proceeds. It also announced a pending sale of Cedar Park Regional Medical Center in Texas expected to bring in $460 million more later in the year, and paired the earnings release with a debt refinancing meant to bring down its debt-to-operating-income ratio.

Even while divesting hospitals, CHS grew same-store operating revenue 3.1% year over year to $3.2 billion, helped by a stronger-than-expected flu season that pushed same-store admissions up 4%, and CEO Tim Hingtgen said the company 'held the line' on supply costs while cutting contract-labor costs by $8 million year over year.

Sold three hospitals for $544M in Q1 2025 alone, with $460M more expected from a pending Texas sale, cutting debt while same-store admissions rose 4%.

CHS had been under financial strain, including a net loss in the prior year, and set a goal of divesting $1 billion in assets to bring down its debt load.

Selling non-core or overlapping hospitals -- in Florida, North Carolina and Mississippi -- let CHS raise cash for debt paydown without touching its core markets.

Executives paired the divestitures with a same-day debt refinancing, aiming to cut the debt-to-operating-income ratio directly rather than wait for organic profit growth to do it.

Deleveraging through targeted asset sales can fund debt paydown without waiting for turnaround profits -- but keep client volumes intact by protecting the assets you keep.

The three completed sales brought in $544 million in cash, and CHS expected roughly $460 million more once its sale of Cedar Park Regional Medical Center in Texas closed later in 2025 -- together approaching its $1 billion divestiture target. Even with a $13 million net loss for the quarter, Jefferies analyst Brian Tanquilut credited the divestiture program with 'enabling [management] to pay down debt' alongside the refinancing. Uncertainty over federal Medicaid supplemental-payment approvals and possible tariff exposure remained headwinds heading into the rest of 2025.

FOLLOW THE EVIDENCE

The sources

  1. CHS emphasizes divestitures, strong volumes in Q1 earnings healthcaredive.com
  2. CHS' losses widen in 2024 healthcaredive.com